Literature DB >> 27002620

Clinical Approaches to the Patient with a Failing Fontan Procedure.

Robert W Elder1, Fred M Wu2.   

Abstract

The Fontan operation has been nothing short of revolutionary in its influence on the modern management of patients born with functionally univentricular hearts. The vast majority of these individuals are now surviving well into adulthood. In the 45 years since its introduction, however, there has been increasing recognition of Fontan survivors as a vulnerable population with an altered physiology that has remarkably broad, adverse impact on their long-term health. In this review, the authors discuss the varied manifestations, both cardiac and extracardiac, of the failing Fontan circulation and potential therapeutic options. In addition, a general clinical approach to the patient presenting with Fontan failure is proposed. Ultimately, the key to improving our care and understanding of the Fontan population lies in multi-institutional collaboration and partnership between subspecialty cardiologists and specialists in other organ systems.

Entities:  

Keywords:  Adult congenital heart disease; Congenital heart disease; Congestive heart failure; Fontan; Hypoplastic left heart syndrome; Single ventricle; Tricuspid atresia

Mesh:

Year:  2016        PMID: 27002620     DOI: 10.1007/s11886-016-0716-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  54 in total

1.  Decompression of thoracic duct: new approach for the treatment of failing Fontan.

Authors:  Viktor Hraška
Journal:  Ann Thorac Surg       Date:  2013-08       Impact factor: 4.330

2.  Hemodynamic phenotype of the failing Fontan in an adult population.

Authors:  Camden L Hebson; Nancy M McCabe; Robert W Elder; William T Mahle; Michael McConnell; Brian E Kogon; Emir Veledar; Maan Jokhadar; Robert N Vincent; Anurag Sahu; Wendy M Book
Journal:  Am J Cardiol       Date:  2013-09-25       Impact factor: 2.778

Review 3.  Protein-losing enteropathy after Fontan operation.

Authors:  Jack Rychik
Journal:  Congenit Heart Dis       Date:  2007 Sep-Oct       Impact factor: 2.007

4.  Congenital enterocyte heparan sulphate deficiency with massive albumin loss, secretory diarrhoea, and malnutrition.

Authors:  S H Murch; P J Winyard; S Koletzko; B Wehner; H A Cheema; R A Risdon; A D Phillips; N Meadows; N J Klein; J A Walker-Smith
Journal:  Lancet       Date:  1996-05-11       Impact factor: 79.321

5.  Clinical outcome of 193 extracardiac Fontan patients: the first 15 years.

Authors:  Salvatore Giannico; Fatma Hammad; Antonio Amodeo; Guido Michielon; Fabrizio Drago; Attilio Turchetta; Roberto Di Donato; Stephen P Sanders
Journal:  J Am Coll Cardiol       Date:  2006-04-27       Impact factor: 24.094

6.  Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan.

Authors:  Orhan Uzun; Joon Kwang Wong; Vinaj Bhole; Oliver Stumper
Journal:  Ann Thorac Surg       Date:  2006-12       Impact factor: 4.330

Review 7.  Thrombosis and thromboembolic complications in fontan patients: a literature review.

Authors:  Mohammed Firdouse; Arnav Agarwal; Anthony K Chan; Tapas Mondal
Journal:  Clin Appl Thromb Hemost       Date:  2014-01-24       Impact factor: 2.389

8.  Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery.

Authors:  Sing-Chien Yap; Louise Harris; Candice K Silversides; Eugene Downar; Vijay S Chauhan
Journal:  J Am Coll Cardiol       Date:  2010-11-02       Impact factor: 24.094

9.  Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study.

Authors:  Robert W Elder; Nancy M McCabe; Camden Hebson; Emir Veledar; Rene Romero; Ryan M Ford; William T Mahle; Brian E Kogon; Anurag Sahu; Maan Jokhadar; Michael E McConnell; Wendy M Book
Journal:  Int J Cardiol       Date:  2013-07-09       Impact factor: 4.164

10.  Hepatocellular carcinoma in two patients with cardiac cirrhosis.

Authors:  Teddy Saliba; Stephan Dorkhom; Eileen M O'Reilly; Emmy Ludwig; Bolorsukh Gansukh; Ghassan K Abou-Alfa
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-07       Impact factor: 2.566

View more
  3 in total

1.  Caval to pulmonary 3D flow distribution in patients with Fontan circulation and impact of potential 4D flow MRI error sources.

Authors:  Kelly Jarvis; Susanne Schnell; Alex J Barker; Michael Rose; Joshua D Robinson; Cynthia K Rigsby; Michael Markl
Journal:  Magn Reson Med       Date:  2018-09-15       Impact factor: 4.668

Review 2.  The failing Fontan.

Authors:  T K Susheel Kumar
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-03-07

3.  A Multimodal Score Accurately Classifies Fontan Failure and Late Mortality in Adult Fontan Patients.

Authors:  Peter Kramer; Anastasia Schleiger; Marie Schafstedde; Friederike Danne; Johannes Nordmeyer; Felix Berger; Stanislav Ovroutski
Journal:  Front Cardiovasc Med       Date:  2022-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.